echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > AP&T: Compared with anti-TNF biologics, Uselizumab is superior in treating Crohn's disease and vedolizumab in treating ulcerative colitis

    AP&T: Compared with anti-TNF biologics, Uselizumab is superior in treating Crohn's disease and vedolizumab in treating ulcerative colitis

    • Last Update: 2021-08-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), can cause intestinal damage, and biological agents can be used to treat patients with IBD


     


     


    Figure: The therapeutic effect of different biological agents on inflammatory bowel disease


    This study confirms that CD patients receiving Uselnumumab and UC patients receiving vedolizumab have the highest efficacy and durability


     

    Original source:

    Yanna Ko.


    Superior treatment persistence with ustekinumab in Crohn's disease and vedolizumab in ulcerative colitis compared with anti-TNF biological agents: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.